2,2,2-Trifluoro-N-(7-hydroxy-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-yl)acetamide

Catalog No. :
ACZZMR578
CAS No. :
866131-56-8
Molecular Formula :
C12H10F3NO4
Molecular Weight :
289.21

IUPAC Name:2,2,2-trifluoro-N-(7-hydroxy-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-yl)acetamide

2,2,2-Trifluoro-N-(7-hydroxy-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$561.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2,2-Trifluoro-N-(7-hydroxy-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-yl)acetamide
IUPAC Name2,2,2-trifluoro-N-(7-hydroxy-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-5-yl)acetamide
MDL No.MFCD03617718
Molecular FormulaC12H10F3NO4
Molecular Weight289.21
SMILESO=C(NC1CC(O)C2=C1C=C3OCOC3=C2)C(F)(F)F
InChI KeyRSKSCGPPHLZLMQ-UHFFFAOYSA-N
Synonym2,2,2-TRIFLUORO-N-(7-HYDROXY-6,7-DIHYDRO-5H-INDENO[5,6-D][1,3]DIOXOL-5-YL)-ACETAMIDE;2,2,2-trifluoro-N-{7-hydroxy-2H,5H,6H,7H-indeno[5,6-d][1,3]dioxol-5-yl}acetamide;Acetamide, N-(6,7-dihydro-7-hydroxy-5H-indeno[5,6-d]-1,3-dioxol-5-yl)-2,2,2-trifluoro-
CAS No.866131-56-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACZZMR578 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZZMR578 route product structure diagram
    ACZZMR578866131-56-8
Inquiry

2. ACZZMR578 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZZMR578 route product structure diagram
    ACZZMR578866131-56-8
Inquiry

Comments (0)